The Royal College of Veterinary Surgeons is warning veterinary surgeons to be on their guard after it came to light that a fraudster is charging a £150 'non-refundable application fee' for an RCVS 'internship' which does not exist. Apart from anything else, the RCVS does not offer internships.
Information about the fake internship has been sent to individuals registered with German website http://www.vetcontact.com/. It includes details about the Royal Veterinary College and the RCVS, but is basically fiction. It refers to a made up 'RCVS Hospital' in the 'Flint Hills of London'.
Gordon Hockey, RCVS Head of Professional Conduct said: "So far, only a handful of veterinary surgeons - all based overseas - have contacted us regarding the internship and queried the request for a non-refundable 'application' fee, although we are concerned that others may have been caught out.
"We would advise any veterinary surgeon to think twice before paying for a third party to facilitate an application for any placement or internship, and reiterate that the RCVS does not offer any such programmes."
The College is following up the situation with http://www.vetcontact.com/ and, if appropriate, will notify the police. In the meantime, anyone who is concerned that they may have fallen victim to the hoax should contact the RCVS Professional Conduct department on 020 7202 0728.
A campaign to reform English libel law to allow for robust criticism of scientific and medical claims without fear of legal action has been launched by journalist and author Simon Singh. It's a campaign which anyone working in the caring professions might wish to support.
The campaign comes as a consequence of legal action taken against Mr Singh by The British Chiropractic Association, which took exception (perhaps unsurprisingly) to an article he'd written in The Guardian. In the article, Mr Singh denounced claims on the BCA website that its members could use spinal manipulation to treat children with colic, ear infections, asthma, sleeping and feeding conditions, and prolongued crying as 'bogus', and criticised the BCA for 'happily promoting' these claims.
Out of curiosity, VetSurgeon rang the BCA press office this morning, and asked to be given the references for studies which it feels would support the original claims made on its site. Non have been forthcoming so far, which is a surprise. Under the circumstances, we'd have expected the BCA would have a raft of supporting evidence readily available.
But this isn't really about whether or not chiropractic works or not. The case seems to hinge upon whether Mr Singh's article implied that the BCA was being deliberately dishonest, or just delusional. He say's the latter. Unfortunately for him, Mr Justice Eady recently ruled the former, leaving Mr Singh with a bill for £100,000 worth of legal fees.
Mr Singh is to appeal. At stake is the freedom to be able to challenge scientific claims without fear of being sued. If you'd like to support this campaign, visit senseaboutscience.com and add your name to the 7000 others (including some pretty illustrious names) who have already done so.
Virbac has launched Propofol-Lipuro Vet, a short-acting intravenously administered and short-term maintenance general anaesthetic for use in dogs and cats.
Propofol-Lipuro Vet contains no preservatives so its use can be repeated, even in cats, for continuous rate infusion. No age restrictions apply to the animals it can be used for and it can be administered for induction prior to Caesarean section.
Virbac Product Manager Kate Woolley MRCVS said: "Propofol is a well-established solution for short-acting anaesthesia in many practices. Propofol-Lipuro Vet complements Virbac's anaesthesia range which now offers total control of analgesia, sedation, intravenous and gaseous anaesthesia, and recovery."
Propofol-Lipuro Vet is available in boxes of 10 x 20 ml bottles.
The company says the new range performs as well as the leading brands and delivers consistently reliable sterilisation, but at a much lower price point than the market has seen before. The entry level 8 Litre machine retails at £1,100.
The Yeson machines range in size from an 8 litre to a 22 litre capacity and offer quiet Class B operation, 7 pre-set sterilisation programs, B&D Helix testing and a choice of printer or USB reporting.
Yeson UK MD Will Thomas said: "The autoclave market has been dominated by a few major players for many years and until now they’ve been largely unchallenged. Many people are now asking “why should I pay thousands more for a utility machine such as an autoclave? We’re just hoping that we can meet the demand."
For more information, visit www.yeson-uk.com
Until now, the treatment has only been available in 20 and 40 pack sizes. The new two-tube pack option offers clients a pre-packaged treatment course for one ear.
Dechra Brand Manager Carol Morgan said: “The introduction of a pre-packaged Osurnia treatment course provides a convenient solution to veterinarians treating otitis. Osurnia comes in pre-measured, single-dose tubes of the gel with a soft flexible applicator tip that ensures the dog receives the right dose, every time, all while minimising discomfort for the patient.
"The patented gel formulation provides reassurance that the solution is less likely to be dislodged from the patient’s ear, prolonging the contact of the active medicines directly at the infection site1.
"A treatment plan using Osurnia means that vets can help ensure compliance of treatment. The application of the second dose provides an additional opportunity to assess the patient to ensure it is responding as planned."
Osurnia two-tube packs are available from wholesalers. For more information, visit: www.dechra.com.
This, says the company, suggests that infection could be more common among seemingly healthy dogs than vets or owners realise, which may mean there is a greater risk of perioperative bleeding caused by the coagulopathies associated with A. vasorum2 than previously thought.
Elanco says another recent study indicates that there may be a bigger environmental risk for dogs than previously thought, too.
In the study, by Robbins et al, L3 larvae of A. vasorum and Crenosoma vulpis arising from the gastropod intermediate host were found to be immediately infective to dogs and remain so for up to eight weeks, meaning that dogs may only need to lick the molluscs’ slime to be at risk of infection.3
Elanco says this new data means A.vasorum should be added to many differential diagnosis lists, and that pre-operative testing could also be wise.
Jenny Helm, BVMS Cert SAM Dip-ECVIM CA FHEA MRCVS, European Specialist in Small Animal Internal Medicine, said: “Owners need to be aware that healthy dogs could be silently carrying and spreading the disease and that asymptomatic carriers could develop clinical signs at any time.
"They need to be aware that dogs don’t necessarily have to eat slugs and snails to become infected, as recent evidence suggest that other routes of transmission are possible.” To improve data on the prevalence of lungworm, Elanco has developed a version of its lungworm map specifically for veterinary surgeons, where you are invited to upload your cases (including asymptomatic positive cases: www.lungwormmap-vet.co.uk.
For those practices which want to run lungworm awareness campaigns in their area, Elanco has a how-to guide, posters and artwork available to download at www.myelanco.co.uk.
References
The expansion has increased the hospital's footprint by 30%, adding three new operating theatres, six new consult rooms and new feline facilities, including a cat-only waiting room, consult room and treatment area.
Hospital owner, IVC Evidensia said the expansion has been driven in part by the pet ownership boom of the last few years and increased demand for the hospital’s services.
To meet the demand, Vale has expanded its office space, adding desk space for a further 25 vets.
There are also new ultrasound and cardiology rooms, a new dental suite and enlarged prep and recovery areas.
The existing kennel area has doubled in size with the addition of nine new walk-in kennels, a bespoke isolation ward and secure outdoor runs.
Richard Artingstall, clinical director at Vale Referrals, said: “We’ve been working on this expansion for a long time and it’s incredible to see it complete.
"Our new and improved facilities mean we can give even more pets across the Southwest the gold standard treatment that they deserve and support our colleagues from neighbouring vet practices with extensive referral services.
"The feedback from pets and owners so far has been very rewarding to hear.”
The feedback from pets?
Really?
VetSurgeon.org contacted recent patient Dougal McDoggins for comment.
He said: "Woof."
www.valereferrals.co.uk.
The BVA Board oversees the performance of the Association and is responsible for corporate and financial governance and for setting the BVA’s strategic direction. It consists of nine members: the three Officers of the BVA, four Directors appointed by BVA Council and up to 2 non-veterinary Directors appointed by the Board. The Chairman is elected by the Board.
Philip, a Bristol University Veterinary School graduate, spent seven years in mixed practice in Sussex, Kent and Suffolk before embarking on a career in the veterinary pharmaceutical industry.
He became CEO of Novartis Animal Health UK Ltd in 1996 (where, incidentally, he was ultimately responsible for signing up a wet-behind-the-ears PR consultant by the name of Arlo Guthrie and giving the go-ahead for the development of vetnurse.co.uk, which in turn led to the launch of vetsurgeon.org). In 2003 he became the company's Head of Global Marketing, and in 2005, Head of Global Business Development.
Philip has also run business elective training at the Royal Veterinary College, which has provided first-hand experience of the concerns and opportunities facing new graduates within a changing profession.
Gudrun Ravetz, President of the British Veterinary Association, said: "We are delighted to announce Philip Lowndes as the new Chairman of the BVA Board. His experience and expertise in business, knowledge of the veterinary profession and involvement with BVA will be of great value as we continue to grow our membership and expand our services and support for vets, especially during the uncertainty caused by Brexit."
Philip holds previous chair experience, as Chairman of the National Office of Animal Health (NOAH) between 1997-2004, and currently sits as Chairman of both the Novartis UK Pension Trustee Board and its Investment Committee. He joined BVA’s Board in 2013 and was re-elected by BVA Council for a second term in 2016. He will be taking over from Derek Williams, who stepped down in March after seven years of tireless work as Chairman.
Gudrun said: "I also want to take this opportunity to thank Derek Williams for all the hard work he has put in over many years. In his role as Chairman Derek’s experience and expertise have been vital in helping BVA grow as an organisation."
Philip said: "I am honoured to be elected as the next Chairman of the BVA and look forward to chairing the Board as it addresses the challenges ahead. The veterinary profession needs and deserves vibrant representation and it is the Board’s role to ensure that the organisation has the ability and the resources to achieve this to the benefit of our membership."
The BVA Board also gained a new non-veterinary Board Director, Steven Anderson Dixon, from April. Mr Dixon brings with him a successful career in newspaper and magazine publishing, which will be an asset as BVA consolidates and continues to develop its portfolio of veterinary journals.
The researchers say that research thus far has focused on developing treatments to manage idiopathic epilepsy and little attention has been given to the emotional and logistical challenges for owners managing their dog’s condition.
This study used semi-structured interviews to explore how owners’ lives were changed following their dogs’ diagnosis and glean in-depth insights into their lives.
The research discovered that following their dog’s initial seizure, all interviewees recalled feeling negative emotions such as being distraught, fearful or uncertain regarding their dog’s future and disease progression. Prior experience with canine epilepsy was rare, and owners were shocked and distressed by the appearance of their dog’s seizures.
Whilst many owners discussed a very emotionally close dog-owner bond, owning a dog with epilepsy had a significant impact on their lifestyle. Impacts affected many aspects of daily routines, and in some cases, owners’ jobs. The unpredictable and sometimes inconvenient timing of seizures negatively impacted owners’ sleep and wellbeing. This unpredictability also made some owners feel that they were living with “a ticking time bomb”.
Other limitations included strict daily medication schedules and difficulty finding assistance in caring for their dog. This, combined with a fear of leaving their dog unsupervised, had social implications in some instances and led to increased use of the Internet and online groups for peer support. Owners also reported that friends, family and colleagues did not always understand the magnitude of commitment required.
Amy Pergande, Small Animal Intern at the RVC and primary author of the study, said: "We are sincerely grateful to the owners who participated in this study for providing us with such detailed and often emotive accounts of their experiences. Many of the participants had willingly altered many aspects of their daily routine for their dogs, both socially and professionally, and sometimes at the expense of their own quality of life."
This research highlights that further consideration of these factors by veterinary professionals and the friends and families of owners of these dogs could improve owner quality of life and facilitate the provision of additional, much needed support.
Rowena Packer, Lecturer in Companion Animal Behaviour and Welfare Science and research lead in canine epilepsy at the RVC, said: "Epilepsy can be an extremely tough condition for owners to manage, where the love, time and money owners dedicate to their dogs is not necessarily matched by a significant improvement in their condition, with seizures often continuing unabated. Our study has revealed previously unrecognised or under-appreciated impacts that epilepsy introduced to these owners’ lives. Improved awareness and understanding of these challenges by veterinary professionals have the potential to improve communication with clients, to avoid owners feeling that social media is the only place they can go to feel supported and understood”.
These findings increase the understanding of the sometimes negative and often profound emotional effects and lifestyle changes experienced by owners managing a dog with idiopathic epilepsy. With better support and resources, the reported impacts could potentially be minimised to protect owner quality of life.
Zoe Belshaw, independent research collaborator, said: “The welfare of pets and their owners can be closely intertwined. This research exploring how owners’ lives change when their dogs develop epilepsy is another important piece in the jigsaw of understanding both what the veterinary profession can do to best support our clients, but also in starting to appreciate the substantial wider societal impacts of chronic ill health in our nations’ pets”.
The full paper is open access and available at: https://bmcvetres.biomedcentral.com/articles/10.1186/s12917-020-02669-w
Reference
Photo: The Melias Studio
The group attributes part of its success to the various initiatives it runs for employees, including a scheme through which every member of its 220-strong team is allowed five fully paid donation days each year so they can volunteer to support meaningful local causes.
Employees also receive a £500 cash gift when they become new parents or adopt a child and can take 'peternity leave', which offers anyone with a new pet two fully paid days off work to help the animal settle into their new home.
Team members also get birthdays off (with cakes), a health care scheme, subsidised Fitbits and gym memberships.
Tim Harrison, managing director at White Cross Vets, said: "Making White Cross Vets a great place to work is vitally important to us, especially because our people are such a fundamental part of our success. Plus we’ve just launched the second of five new practices that will open during a 12-month period, so we’re continually expanding and recruiting.
"Being at the forefront of the veterinary industry with a wide range of innovative and high-quality employment initiatives, many of which are ideas from individual team members, helps us to attract and retain the best people. This enables us to grow quickly whilst fostering a close-knit and highly motivated team. This ethos also translates into the level of care and standard of service that our clients receive, which is something we’re very proud of."
The new methods, published in Applied and Environmental Microbiology, use a simple swabbing technique to gather samples from the environment which FMD-susceptible animals such as cattle, sheep and pigs commonly make contact with, such as water troughs.
Researchers say the technique requires very little expertise, which makes the sampling method far more accessible, allowing a higher frequency of samples to be collected and processed during an outbreak.
FMD virus is able to survive long periods of time in the environment in the right conditions (up to three months depending on environmental factors such as pH, temperature and relative humidity), so sampling areas where infected animals may have shed virus allows scientists to detect the presence of FMD even if the animals on the farm are no longer showing clinical signs.
The researchers say that novel surveillance techniques such as this can help support a robust response to outbreaks in FMD-free countries, and can also be implemented in endemic areas, such as parts of Asia, Africa and the Middle East, as part of surveillance programs to supplement current information about the spread of FMD.
Dr Claire Colenutt, who led the research at Pirbright said: "Current surveillance methods rely on the recognition of FMD infection in susceptible animals in addition to the collection of samples from the animals which requires veterinary expertise. In keeping the approach simple, samples can be taken by individuals without prior expertise, increasing the number of potential samples, and relieving pressure on veterinary services."
Photo: FMD. Dr. D. Denev
Cats Protection is calling for an urgent shift in pet owners' thinking in order to control the UK's cat population, after being inundated with thousands of unwanted kittens again this summer.
The charity is urging owners to neuter their cats at four months of age - two months earlier than the traditional six months - because this is when cats reach sexual maturity.
The call follows a recent survey carried out by the charity which found that just 4% of people neutered their cat at or before the recommended four months.
Each year, Cats Protection takes in thousands of unwanted or abandoned kittens which are the result of unplanned breeding so the charity is keen to make cat owners aware of the need to neuter.
Jane Clements, Cats Protection's Neutering Manager said: "Getting the neutering message across is proving to be a very tough hurdle for cat welfare because our research shows the vast majority of people are still not neutering their cats early enough to avoid unwanted litters of kittens.
"Without neutering, the UK's cat population quickly gets out of control and each summer we are overwhelmed with kittens in need of homes so it is vital people ensure their cats are neutered at the correct age to prevent unwanted litters."
While the lack of early neutering was a problem across Britain, the survey found the ITV Yorkshire and ITV Central areas are the least likely to neuter at the recommended age, both with just 1% of cats neutered at or before four months.
Cats Protection is planning to open a new homing centre later this year in Gildersome, Leeds, Yorkshire, and it is hoped its presence there will raise awareness of the need for better cat welfare and early neutering. The centre will find homes for around 500 cats each year, increasing the charity's work in the region by up to 68 per cent. Information about the new centre can be found by visiting www.cats.org.uk/support-us/future-for-cats/gildersome-homing-centre.
The charity is also embarking on a large scale neutering campaign in North Birmingham, which it hopes will help to raise awareness of the issues in the area.
Cats Protection runs a national register of veterinary practices that carry out neutering at four months of age. To register your practice, please visit the website at www.cats.org.uk/early-neutering
Vet Futures, the joint initiative by the RCVS and BVA to stimulate debate about the future of the profession, has opened a new discussion hospice care, and whether it it will become mainstream in veterinary medicine.
This month's Vet Futures guest blogger, Kath Dyson, a former veterinary surgeon who qualified from Glasgow in 1989, writes that veterinary palliative care, while a relatively recent phenomenon, has been growing in stature, particularly in the United States, with symposia and conferences on the subject as well as webinars and chapters in text books.
She notes the increasing number of UK vets offering hospice care, highlighting the differences between palliative services offered in human and veterinary medicine as well as debates within the profession over the advantages and disadvantages of palliative care versus euthanasia.
She said: "In animal hospice it is the pet's owner who takes on all the financial, practical and emotional costs involved, whereas human patients have a lot more support available. Euthanasia is always an option in veterinary medicine, and indeed euthanasia of an animal can legally be carried out by anyone, so long as it is done humanely."
On the euthanasia debate she adds: "Some regard euthanasia as more of a last resort, with hospice assisted natural death being seen as more preferable and only a minority of patients requiring euthanasia. Others feel that euthanasia is more often likely to be the preferable outcome of a period of hospice care in the animal patient, even though they do not rule out a natural death."
Overall she argues that additional expertise from veterinary surgeons in end of life care will help the profession be "even better able to provide truly lifelong care to all their animal patients".
To accompany Kath Dyson's article, this month's poll asks if hospice care will become a standard part of practice.
Last month's poll asked if vets are given adequate information, guidance and support on ethnic and cultural diversity in relation to a blog written by a British Asian vet about prejudice he encountered from a client. The vast majority (90%) of the 118 people who responded to the poll thought that the profession was lacking in support when it came to diversity. Diversity in the profession and how to increase it has been a key topic identified by the project and it will be one of the issues addressed in the final Vet Futures Report published later this year.
To take part in this month's poll and to read and comment on Kathy Dyson's blog visit www.vetfutures.org.uk/discuss
Described as a first-of-its-kind, mobile-enabled digital whitepaper, the publication offers veterinary surgeons and farmers a resource on ketosis, scientific insights on the impact of the disease, and tools to help optimize dairy herd management.
According to the company, the whitepaper reveals that ketone bodies play a more significant role in metabolic diseases than was previously realized, and that beta-hydroxybutyrate is a good indicator of the presence of subclinical ketosis in dairy cattle.
Rinse Boersma, Dairy Species Manager, Animal Health, Bayer said: "Recognizing the significance of ketone bodies is a positive step towards further enhancing dairy cattle health and welfare. Veterinarians can now reliably detect the presence of subclinical ketosis in dairy herds with a simple blood test, and act quickly with the appropriate corrective measures to arrest disease progression."
Also at Congress, Bayer revealed its enhanced BCS Cowdition smartphone application, designed to support ease and accuracy of body condition scoring (BCS) of dairy cows. Bayer says the upgrade helps farmers to improve herd health management by enabling assessment of individual cows’ BCS scores based on its lactation cycle, alerts for cows that need to be attended to, and a dashboard that offers farmers an overview of their entire herd’s health.
BCS Cowdition is available in 10 languages and is free for download from the AppStore and GooglePlay.
The research also found that awareness of feline hypertension amongst cat owners is very low, with 80% of those questioned unaware that cats could have high blood pressure and nearly 20% believing that it was only an issue in humans.
Amongst those cat owners who are aware of feline hypertension, only 25% said they would consider asking their vet for a blood pressure check for their pet.
However, once made aware of the risks of high blood pressure, including blindness, seizures and kidney disease, 83% of owners said they would ask their vet for a blood pressure test for their cat.
Dr Natalie Borrill MRCVS, veterinary technical manager for cardionephrology at Ceva Animal Health, said: "Feline hypertension is a common condition in older cats; it is estimated that one in five cats from nine years of age are at risk of suffering from the condition3, but there is a low level of awareness amongst cat owners about this condition.
"By increasing awareness of the disease amongst owners, they will be more inclined to visit the vet with their older cat for regular blood pressure checks. It can also be very helpful for an owner to be present when blood pressure is measured because this can help reduce stress and anxiety in their cat. For more information cat owners can visit amadeus.vet."
The research results were released as part of Feline Hypertension Month, which is running until the end of May to raise awareness of hypertension and improve the detection and management of high blood pressure in cats. As part of the campaign, veterinary practices are being urged to measure their feline patients' blood pressure in cats over the age of seven.
Ceva says it will continue its Mercury Challenge throughout 2019 to increase veterinary professionals' confidence in measuring blood pressure and identifying feline hypertension. Participating practices are given the opportunity to win diagnostic tools to help them identify feline hypertension.
For information, contact cevauk@ceva.com or visit mercurychallenge.ceva.com.
At the hearing, Dr Crawford made no admissions to the charges against him which involved allegations of: failing to provide adequate and appropriate care; failing to provide adequate clinical histories to another practice in respect of several animals; failing to treat fellow veterinary professionals and other members of staff from another practice with courtesy and respect; failing to maintain adequate clinical records; failing to have in place Professional Indemnity Insurance or equivalent arrangements; and, failing to respond to reasonable requests from the RCVS.
Dr Crawford’s representative drew the Committee’s attention to the fact that Mr Crawford was 71 years old, had no previous disciplinary findings against him and had now ceased practising, including closing his practice premises and notifying his previous clients of the closure.
His representative confirmed that Mr Crawford was fully aware that if his application was accepted, he would no longer be able to practise as a veterinary surgeon or identify as a veterinary surgeon. The Committee also noted that the RCVS had consulted with the complainants who were satisfied with the case being disposed of in this way.
Dr Martin Whiting, chairing the Committee, and speaking on its behalf, said: “Having weighed the public interest in a hearing with the registrant’s interests, the Committee determined that this is not a case in which the public interest required there to be a full hearing. Protection of the welfare of animals would also not be further served by a full hearing. The Committee decided to accede to the respondent’s application.
"The Committee considered that the adjournment on undertakings served to protect the public interest, confidence in the profession and the welfare of animals.
"The Committee carefully considered the detail of the undertakings. It decided, after due consideration that it would accept the respondent’s undertakings in the terms offered and signed."
The Committee also heard that if Dr Crawford were to apply to re-join the Register at a future point, then the adjourned case would be re-opened and a full, public Disciplinary Committee hearing would be held.
The full documentation for the case can be found at: www.rcvs.org.uk/disciplinary
Canaural contains fusidic acid, framycetin and nystatin for their antibacterial and antifungal effects against the most common organisms associated with otitis externa.
Fusidic acid has skin penetrating properties and is active against staphylococci and streptococci1. Framycetin is active against Gram negative species. Dechra says the combination of the two provides an enhanced antibacterial effect on the most common bacterial cause of canine otitis2.
Nystatin is active against malassezia and prednisolone helps to provide anti-inflammatory and anti-pruritic action.
Dechra Brand Manager Carol Morgan said: “The reintroduction of Canaural to the veterinary treatment market means that once again veterinarians have this reliable and effective treatment available to tackle one of the most common canine complaints.
"Canaural is a tried and tested product and a recent study showed that fusidic acid is highly efficacious against both methicillin sensitive and methicillin resistant strains of Staphylococcus pseudintermedius3. Canaural remains as relevant today as it has ever been."
Canaural comes in 15 ml and 25 ml bottle sizes and is now available in veterinary wholesalers.
The guide has been written by Simon Tappin, European and RCVS Recognised Specialist in Veterinary Internal Medicine at Dick White Referrals, and is designed to offer practical advice on the appropriate use of antibiotics in general practice. It covers a range of topics including how to create an antibiotic practice policy, ways to optimise therapy and how to limit the development of antimicrobial resistance.
Simon said: "Making rational and informed antimicrobial choices is vitally important in veterinary medicine, both for the welfare of our patients and in reducing the risk of developing antimicrobial resistance.
"Highlighting this issue to vets, providing education and supporting them in making these decisions is crucial to ensure a responsible approach to antimicrobial prescribing."
Recent surveys have highlighted the need for education on this topic, with 63 per cent of vets1 stating that they would like to improve their knowledge on antimicrobials, and 90 per cent of vets2 admitting that they are concerned about antimicrobial resistance.
In addition, there's a quiz where you can test and your knowledge on antimicrobials, and enter a competition to win an iPad Pro. The quiz can be accessed at https://veraflox.typeform.com/to/KY8lxX.
The guide is available from the Bayer Vet Centre, www.vetcentre.bayer.co.uk. Alternatively, you can download it here www.bit.ly/Veraflox2016 or contact your local Bayer Territory Manager.
The award was due to be presented at the association's annual shindig in March, which was cancelled due to the coronavirus pandemic.
VMA Awards chair, Claire Edmunds, said: “This years’ winners will still get their moment of glory on stage next March at the rescheduled event. We can also announce that the event is likely to include some additional categories to recognise campaigns and initiatives undertaken during the COVID-19 pandemic.”
Carlos Michelsen, managing director of award sponsor, CM Research, added: "Thanks to the continued success of Cytopoint, Zoetis achieved highly commended status. But it was Elanco that came in as award winners, with their novel veterinary pharmaceutical product Galliprant taking the crown. Congratulations to Elanco!"
Rebecca Bryant, Elanco’s marketing manager for Pet Health Therapeutics (pictured right), said “Elanco is delighted to be recognised by the veterinary community with this prestigious award for Galliprant. The UK team is proud to be part of the launch of this innovative, first-in-class product which has already enriched the lives of thousands of pet owners and their dogs living with osteoarthritis. It’s fantastic to hear from vets that managing OA with Galliprant has already made a positive impact on their practices.”
Zoetis product manager, Allison Henry said: “We are very proud to come such close second in this award category as it is a true testament to the lasting innovation Cytopoint has brought to our industry, customers and pets. At Zoetis, we always strive to develop innovative new medicines for the veterinary industry and we are thrilled to see how Cytopoint has done just that.”
Micro-nutrition specialist Agrimin has launched All-Trace Biotin Gold, the seventh bolus in the company's All-Trace range.
The new bolus is the result of extensive in-house research and development which aimed to formulate a cost-effective, micro-nutrition bolus suitable for dry cows and heifers at risk from lameness, which affects up to 20 per cent of the UK national herd. According to Agrimin, the relationship between Biotin and its benefits on ruminant hoof health is receiving increasing attention. The company says it is the first micro-nutrition specialist to directly address this livestock health issue by using a bolus.
The Biotin Gold bolus for dairy cows and heifers delivers the target level of 20 mg per head, per day of Biotin over 120 days. In addition, the bolus also delivers the full, daily requirement of copper, cobalt, selenium and iodine as well as levels of zinc, manganese and vitamins A, D3 and E.
Administration is simple and convenient during the drying off period as many livestock are already going through a crush to have their feet trimmed and undergo other healthcare routines such as intramammary treatments.
For dry cows, two boluses are given to each cow at the point of drying off. They lie in the rumen/reticulum and slowly dissolve from a constant surface area providing a continuous and regular supply of trace elements and vitamins to the animal. The boluses dissolve completely and leave no residue in the rumen.
Agrimin says heifers respond very well to Biotin supplementation and studies have shown that supplying Biotin in the later stages of pregnancy produces the most effective results. This late stage of pregnancy is also the critical period for the transfer of vital nutrients from mother to calf and so the trace element content of All-Trace Biotin Gold will benefit both animals. Two boluses are given to each heifer at around three months pre-calving.
All-Trace Biotin Gold is available in packs of 20 boluses, which will supplement 10 cows or heifers at a cost of around £9.50 per animal for two boluses. For more information about bolus technologies and micro-nutrition, please visit www.agrimin.com or call 01652 688046.
The protocol provides evidence-based best practice criteria so that hospitals and other health settings can introduce animals into the care environment.
By following it, the RCN says services will be able to ensure the safety of patients and health care staff as well as the animals and their owners, while allowing patients to reap the benefits that interaction with animals can bring.
Publication of the protocol was prompted by an RCN survey last year which found that although the majority of respondents thought animals were hugely beneficial to patients, most nurses said animals were not allowed in their workplace.
The survey found that nine out of 10 nurses believe animals can help improve the health of patients with depression and other mental health problems with 60% of respondents also acknowledging that animals can help speed patient recovery.
Amanda Cheesley, RCN Professional Lead for Long-term Conditions and End-of-Life Care, said: "Anyone who’s worked in this area can see the amazing impact animals have on the health of adults and children alike.
"However there are so many myths around the dangers of having animals in health care settings that most organisations are too concerned to try it out.
"This protocol will help to dispel these fears by supporting hospitals to include animals in the care they deliver in a safe and professional way.
"We hope that it will encourage all health services to consider how animals can help their patients and help us to remove the taboo from what is a really remarkable area of care."
The protocol has been welcomed by the British Veterinary Association. Simon Doherty, BVA Junior Vice President, said: "This new protocol highlights the importance of the bond between humans and animals. It also serves as a welcome reminder at the start of Mental Health Awareness Week of how caring for and interacting with ‘man’s best friend’ can help to relieve stress and enhance wellbeing and a sense of companionship.
"It’s positive that the working group consulted with a wide range of organisations on welfare and safety considerations in developing this protocol, as ensuring the wellbeing of both humans and animals in these settings is paramount. As a fellow member of the UK One Health Coordination Group, BVA is very pleased to see a joined-up and forward-thinking approach to this important area of work."
Photo: Therapy Dog Visiting Young Female Patient In Hospital, Monkey Business Images / Shutterstock
The competition is open to all UK-based undergraduate veterinary students and offers them the opportunity to work as a team to brainstorm, develop and present an innovative idea to a board of industry professionals.
Students can enter either as a single applicant or as a group (of roughly five members), with single applicants then being placed in a group with other applicants from their university. There can be more than one team representing each university.
Each student’s project can cover any aspect of veterinary health innovation. The RCVS suggests potential projects might include: innovations within veterinary education, innovations to improve sanitation and hygiene, innovations to improve veterinary-public communication and innovations to improve patient safety.
Entries must show how they have improved upon – or extended beyond – current expectations of best practice in their chosen area.
Each applicant will receive support from one of the Association of Veterinary Students’ (AVS) Vet Futures Ambassadors, as well as a mentor session with a chosen industry professional to guide them on their project.
Teams will need to submit three components for judging: a log of their progress throughout the project (which can include social media updates using the hashtag #ViVetStudentInnovation), mentor engagement and feedback, and a five-minute video ‘business pitch’.
The three finalist groups of the competition will be invited to present their pitch to a board of industry professionals at a ‘Dragon’s Den’ style event held at the RCVS ViVet 2019 Innovation Symposium on Tuesday 1 October 2019 in Manchester.
The winning and runner-up groups will then be selected and will be presented alongside the ‘mentor’s choice’ award. The Mentor’s Choice award will be selected by the team mentors. The prize will be awarded to an individual who shows excellence and enthusiasm within their work on the project.
Anthony Roberts, RCVS Director of Leadership & Innovation (pictured right), said: "This competition provides a great opportunity for veterinary students to engage with their fellow classmates across different fields of study and to work on projects that could genuinely make a difference to animal health and welfare and the way veterinary services are delivered. Teams will receive one-on-one mentoring and will be guided through the innovation process, developing skills that will be useful throughout their careers. We look forward to seeing the three finalist teams presenting at the RCVS ViVet Innovation Symposium in Manchester on 1 October."
Zoe Skinner, Vet Futures Student Representatives Team Leader, said: “This competition is a great opportunity for veterinary students to receive mentoring from experienced veterinary professionals and form contacts within our profession. It gives students a way to work together as a team and allows them to learn how to produce and develop innovative, problem-solving concepts as well as skills in delivering presentations. These are all important aspects of our career ahead, which will look brilliant on our CV’s.”
ViVet is now accepting registrations for the competition for the 2018/19 academic year. To enter, applicants must submit an online registration form. For further information, email info@vivet.org.uk.
The first cohort of students started the course in September 2014 and graduated in July 2019 this year. During that time, the College worked with the University to make sure its programme was developed to meet RCVS standards. That included interim visitations by a team of accreditation reviewers and a final accreditation visitation by representatives of the RCVS, the Australasian Veterinary Boards Council (AVBC) and the South African Veterinary Council (SAVC).
After the final visitation, a report was submitted to the RCVS Primary Qualifications Subcommittee (PQSC), which then recommended to the Education Committee that the RCVS recognises the University of Surrey’s veterinary degree (subject to satisfactory external examiner reports, which were subsequently received). In turn, the RCVS Council then approved the degree last week.
Dr Sue Paterson, the Chair of the Education Committee, said: "We are very glad to have reached the stage where we can formally welcome the University of Surrey on board as the eighth UK veterinary school to offer an approved degree, and that we will, from now on and pending Privy Council’s approval, be able to welcome its graduates onto the Register as proud members of the RCVS.
"We appreciate the immense hard work of both the faculty and the student body over the past five years in working to meet the College’s stringent accreditation standards and the effort that they have made to address our feedback and advice in a constructive and engaged way.
"When I observed at the final accreditation visit earlier this year I, along with the other visitors, was particularly impressed with the enthusiasm and commitment of the staff, the network of partner veterinary practices and the student body to the school’s ethos and success. We also recognised that, with its unique ‘distributive model’ meaning that students can get direct clinical experience across 49 veterinary practice partners, the students have access to a large and diverse medical and surgical caseload.
"The final report contained a number of further recommendations and we look forward to continuing to work with the school over the next two years to help them meet our recommendations and suggestions."
Professor Chris Proudman, Head of School of Veterinary Medicine at the University of Surrey, added: "I am delighted that our new degree programme in veterinary medicine and science has been approved by RCVS Council for recognition by the Privy Council.
"This decision recognises the huge investment in veterinary education made by the university and the quality of the education that we offer. It is also validation of our innovative model of delivering clinical teaching through working in partnership with clinical practices and other organisations involved in animal health, which has proven very popular with our students."
“The commitment and enthusiasm of our partners has been truly inspiring and energising. I look forward to Surrey veterinary graduates making valuable contributions to the profession in a variety of ways over the coming years.”
A Recognition Order to recognise the University of Surrey’s Bachelor of Veterinary Medicine and Science (BVMSci Hons) will now be put before the Privy Council and, if it approves the Order, this will then be laid before Parliament. If the Order is approved by both the Privy Council and Parliament, the University of Surrey will then enter the cyclical RCVS accreditation process and be subject to annual monitoring.
The executive summary of the final visitation report can be found in the papers for the October 2019 meeting of RCVS Council: https://www.rcvs.org.uk/who-we-are/rcvs-council/council-meetings/3-october-2019/. The full report will be published in due course.
Picture shows:(from left to right) Dr Susan Paterson, Chair of the RCVS Education Committee; Professor Chris Proudman, Head of School of Veterinary Medicine at the University of Surrey; and Dr Niall Connell, RCVS President.
The charity points out that with the arrival of winter, so comes an increase in the number of cats poisoned by antifreeze. For this reason, it has produced the poster to try and raise awareness of the fact that due to their specialised metabolism, a teaspoon or less of antifreeze can be enough to cause serious illness or death and even a curious lick of a small spillage can be enough to poison a cat.
The poster can be downloaded free of charge here: https://icatcare.org/sites/default/files/PDF/antifreeze-campaign-poster.pdf.
Alternatively, a hard copy can be ordered from the iCatCare shop for a small fee to cover postage: https://icatcare.org/product/antifreeze-poster
More information for pet owners can be found at: https://icatcare.org/advice/keeping-cats-safe/antifreeze
Vetoquinol has announced the launch of its new support package to help vets and owners manage canine epilepsy with Epiphen, the company's phenobarbital medication.
Each Epiphen support package contains:
Accurate information is vital to help control epilepsy patients and the Owner Record Manual will enable owners to keep on top of this information. It contains charts to monitor seizure frequency and patterns, medication changes, blood test results and seizure characteristics.
The new "ask the expert" scheme offers vets the opportunity to ask for advice on epilepsy cases. Email epiphen@vetoquinol.co.uk with the query (and your contact details) and you will be put in touch with a neurology expert at a leading referral centre. Vets can also contact the Technical Helpline on 0800 1698197.
The Seizure Reports for vets provide a much more detailed tool for use at initial presentation or for owners to fill in when seizures differ in character. There is a pad of 30 tear-off sheets in each Epiphen support package.
Simon Boulton, Epiphen product manager said: "We understand that epilepsy is an emotional condition and wanted to provide vets and owners with more than just a tablet. I am convinced that with the Epiphen Support Package we are providing them with the tools they need to make the most of epilepsy management."
Epiphen also offers a free phenobarbital monitoring service. There is a voucher in each 30mg pack and 2 in each 60mg pack.
For more details on the Epiphen Support Package, to obtain a free practice starter pack or get extra copies of materials, please contact Vetoquinol on 0800 1608197 or contact your Vetoquinol representative.